Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$4.06M-$4.06MderivedN/M vs Q4 2023 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$4,146,182N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,420,984N/M Free Cash Flowderived-$4,435,891N/M ended Dec 31, 2024 · filed Feb 27, 2025 · 58 d after period end